Dermatitis atopic
Not recruitingJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
- Disease:Dermatitis atopic
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Janssen - Cilag International
Rare diseases
Investigational molecules
Locations
Back to Germany39 clinical trials in Blankenfelde-Mahlow, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating new therapeutic approaches for moderate to severe plaque psoriasis, including multiple clinical trials testing novel treatments and comparing their effectiveness to existing options.
Multiple promising compounds being investigated to expand treatment options for patients with persistent symptoms.
Innovative research focusing on moderate to severe atopic dermatitis, investigating both standalone treatments and combination therapies with topical corticosteroids.
Emphasis on developing solutions for patients who haven't responded well to conventional treatments.
Research encompassing various skin conditions including chronic hand eczema, vitiligo, and hidradenitis suppurativa.
Focus on developing effective treatments for conditions that significantly impact quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.